Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,791 | 10,814 | 13,703 | 9,056 | 12,972 |
| TOTAL | $9,971 | $12,296 | $15,181 | $10,321 | $14,276 |
| Non-Current Assets | |||||
| PPE Net | 5 | 7 | 10 | 12 | 14 |
| Intangibles | 0 | 1,867 | 1,867 | 1,867 | 1,867 |
| Other Non-Current Assets | 955 | 1,048 | 1,158 | 1,251 | 869 |
| TOTAL | $960 | $2,922 | $3,035 | $3,130 | $2,750 |
| Total Assets | $10,931 | $15,218 | $18,216 | $13,451 | $17,026 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 329 | 256 | 753 | 480 | 689 |
| Accrued Expenses | 813 | 1,228 | 1,022 | 2,591 | 1,845 |
| TOTAL | $1,322 | $1,661 | $1,948 | $3,241 | $2,534 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 144 | 191 | 236 | 281 | 0 |
| TOTAL | $144 | $191 | $236 | $281 | $N/A |
| Total Liabilities | $1,466 | $1,852 | $2,184 | $3,522 | $2,534 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 893 | 721 | 721 | 717 | 525 |
| Common Shares | 1 | 13 | 13 | 9 | 9 |
| Retained earnings | -57,582 | -53,438 | -50,545 | -46,452 | -41,571 |
| TOTAL | $9,465 | $13,366 | $16,032 | $9,929 | $14,492 |
| Total Liabilities And Equity | $10,931 | $15,218 | $18,216 | $13,451 | $17,026 |